Regions Financial’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-11
Closed -$236K – 904
2016
Q1
$236K Hold
11
– – ﹤0.01% 799
2015
Q4
$229K Hold
11
– – ﹤0.01% 818
2015
Q3
$227K Hold
11
– – ﹤0.01% 837
2015
Q2
$285K Hold
11
– – ﹤0.01% 782
2015
Q1
$219K Hold
11
– – ﹤0.01% 852
2014
Q4
$146K Hold
11
– – ﹤0.01% 903
2014
Q3
$178K Buy
+11
New +$179K ﹤0.01% 1074

Other funds holding TOVX

Regions Financial's TOVX Position: Q2 2016 in Review

Regions Financial sold out of Theriva Biologics (TOVX) in Q2 2016, closing a stake of 11 shares — an estimated $236K sold.

Regions Financial first reported a position in TOVX in Q3 2014 and held it in 7 quarters. The position peaked at $285K in Q2 2015. 61 funds tracked by Wall St. Rank hold TOVX as of Q2 2016.

  • Regions Financial reported no remaining Theriva Biologics position as of Q2 2016 after selling out during the quarter.
  • Regions Financial sold 11 Theriva Biologics shares in Q2 2016, an estimated $236K.
  • Regions Financial first reported a position in Theriva Biologics in Q3 2014 and held it in 7 quarters.
  • Regions Financial's Theriva Biologics position peaked at $285K in Q2 2015.
  • 61 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2016.

Based on Regions Financial's 13F filing for Q2 2016, filed 26 Jul 2016.